GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Roquefort Therapeutics PLC (LSE:ROQ) » Definitions » Purchase Of Investment

Roquefort Therapeutics (LSE:ROQ) Purchase Of Investment : £0.00 Mil (TTM As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Roquefort Therapeutics Purchase Of Investment?

Roquefort Therapeutics's purchase of investment for the six months ended in Dec. 2024 was £0.00 Mil. It means Roquefort Therapeutics spent £0.00 Mil on purchasing investments. Roquefort Therapeutics's purchase of investment for the trailing twelve months (TTM) ended in Dec. 2024 was £0.00 Mil.

Compared with last quarter (£0.00 Mil in Jun. 2024 ), Roquefort Therapeutics spent the same money on purchasing investments in Dec. 2024 (£0.00 Mil).


Roquefort Therapeutics Purchase Of Investment Historical Data

The historical data trend for Roquefort Therapeutics's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Roquefort Therapeutics Purchase Of Investment Chart

Roquefort Therapeutics Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Purchase Of Investment
- - - -

Roquefort Therapeutics Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Purchase Of Investment Get a 7-Day Free Trial - - - - -

Roquefort Therapeutics Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Roquefort Therapeutics Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Roquefort Therapeutics's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Roquefort Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
85 Great Portland Street, First Floor, London, GBR, W1W 7LT
Roquefort Therapeutics PLC is engaged in pursuing opportunities to acquire medical biotechnology businesses. Its product portfolio consists of MDK Antibody, MDK Oligo, MDK mRNA, STAT-6 siRNA, and MK Cell. The principal activity of the Company is to develop pre-clinical next-generation medicines focused on hard-to-treat cancers.

Roquefort Therapeutics Headlines

No Headlines